Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Reed

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
The Journal of Experimental Medicine|October 24, 2007
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escapeNicholas J Maness, Laura E Valentine, Gemma E May, et al.
Frontiers in Immunology|June 26, 2020
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth DevelopmentDelphine C Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, et al.
Plos Pathogens|May 17, 2014
T cell inactivation by poxviral B22 family proteins increases viral virulenceDina Alzhanova, Erika Hammarlund, Jason Reed, et al.
Journal of Virology|December 29, 2006
The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escapeJohn T Loffredo, Benjamin J Burwitz, Eva G Rakasz, et al.
Science Immunology|October 11, 2024
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8<sup>+</sup> T cellsDaniel Malouli, Husam Taher, Mandana Mansouri, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
JCI Insight|August 8, 2024
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primatesGabriela M Webb, Kristin A Sauter, Diana Takahashi, et al.
Journal of Virology|March 29, 2013
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaquesStéphane Champiat, Keith E Garrison, Rui André Saraiva Raposo, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
The Journal of Experimental Medicine|October 24, 2007
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escapeNicholas J Maness, Laura E Valentine, Gemma E May, et al.
Frontiers in Immunology|June 26, 2020
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth DevelopmentDelphine C Malherbe, Constantinos Kurt Wibmer, Molati Nonyane, et al.
Plos Pathogens|May 17, 2014
T cell inactivation by poxviral B22 family proteins increases viral virulenceDina Alzhanova, Erika Hammarlund, Jason Reed, et al.
Journal of Virology|December 29, 2006
The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escapeJohn T Loffredo, Benjamin J Burwitz, Eva G Rakasz, et al.
Science Immunology|October 11, 2024
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8<sup>+</sup> T cellsDaniel Malouli, Husam Taher, Mandana Mansouri, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
JCI Insight|August 8, 2024
Effect of metabolic status on response to SIV infection and antiretroviral therapy in nonhuman primatesGabriela M Webb, Kristin A Sauter, Diana Takahashi, et al.
Journal of Virology|March 29, 2013
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaquesStéphane Champiat, Keith E Garrison, Rui André Saraiva Raposo, et al.
Pageof 12